TNF-α and leptin in experimental liver fibrosis models induced by carbon tetrachloride and by common bile duct ligation

Cell Biochemistry and Function

Volumn 22, Issue 6, 2004, Pages 359-363

  Bahçecioǧlu, Ibrahim Halil ^a   Yalniz, Mehmet ^a   Ataseven, Hüseyin ^a   Bülbüller, Nurullah ^a   Keçeci, Muzaffer ^a   Demirdaǧ, Kutbeddin ^a   Özercan, Ibrahim ^b   Ü̈stü̈ndag, Bilal ^a  

^a FIRAT UNIVERSITY   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

Author keywords

Carbon tetrachloride; Common bile duct ligation; Leptin; Liver fibrosis; TNF

Indexed keywords

CARBON TETRACHLORIDE; INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CELL PROLIFERATION; COMMON BILE DUCT; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL MODEL; EXTRACELLULAR MATRIX; HISTOPATHOLOGY; INFLAMMATORY CELL; LIPID PEROXIDATION; LIVER FIBROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SATELLITE CELL; STEATOSIS; STRAIN DIFFERENCE;

ANIMALS; CARBON TETRACHLORIDE; COMMON BILE DUCT; DISEASE MODELS, ANIMAL; LEPTIN; LIGATION; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; RATS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 8744318240     PISSN: 02636484     EISSN: None     Source Type: Journal    
DOI: 10.1002/cbf.1114     Document Type: Article

References (32)

1. Olaso E, Friedman SI. Moleculer regulation of hepatic fibrogenesis. J Hepatol 1998; 29: 836-847.
2. Peres W, Tunon MJ, Collado PS, Herrmann S, Marroni N, Gonzales-Gallego J. The flavonoid quercetin ameliorates liver damage in rats with biliary obstruction. J Hepatol 2000; 33: 742-750.
3. Recknagel RO, Glende EA, Dolak JA, Waller RL. Mechanisms of carbon tetrachloride toxicity. Pharma Ther 1989; 43: 139-154.
4. Slater TF. Free radicals as reactive intermediates in injury. In Biological Reactive Intermediates II: Chemical Mechanisms and Biological Effects, Snyder R, Parke DV, Kocsis JJ, Jollow DJ, Gebson GG, Witmer CM (eds). Plenum Press: New York, 1982; 575-589.
5. Brattin WJ, Glende EA, Recknagel RO. Pathological mechanisms in carbon tetrachloride hepatotoxicity. J Free Rad Biol Med 1985; 1: 27-28.
6. Aleynik SI, Leo MA, Ma X, Aleynik MK, Lieber CS. Polyenylphosphatidylcholine prevents carbon tetrachloride-induced lipid peroxidation while it attenuates liver fibrosis. J Hepatol 1997; 27: 554-561.
7. Simeonova PP, Gallucci RM, Hulderman T, et al. The role of tumor necrosis factor-α in liver toxicty, inflammation, and liver fibrosis induced by carbon tetrachloride. Toxicol Appl Pharmacol 2001; 177: 112-120.
8. Fox ES, Kim JC, Tracy TF. NF-κB activation and modulation in hepatic macrophages during cholestatic injury. J Surg Res 1997; 72: 129-134.
9. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763-770.
10. Auwerx J, Staels B. Leptin. Lancet 1998; 351: 737-742.
11. Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin. Science 1996; 274: 1185-1188.
12. Kaplan LM. Leptin, obesity, and liver disease. Gastroenterology 1998; 115: 997-1001.
13. Tobe K, Ogura T, Tsukamato C, et al. Relationship between serum leptin and fatty liver in Japanese male adolescent university students. Am J Gastroenterol 1999; 94: 3328-3335.
14. Leclercq IA, Farrell GC, Schriemer R, Robertson GR. Leptin is essential for the hepatic response to chronic liver injury. J Hepatol 2002; 37: 216-213.
15. Beyaert R, Buetler B. The tumour necrosis factor ligand and receptor families. N Engl J Med 1996; 334: 1717-1725.
16. Mario LA, Chiu H, Sprowles KA, et al. Distinct roles of tumour necrosis factor-alpha and nitric oxide in acute liver injury induced by carbon tetrachloride in mice. Toxicol Appl Pharmacol 2001; 1: 172: 44-51.
17. Czaja MJ, Xu J, Alt E. Prevention of carbon tetrachloride-induced rat liver injury by soluble tumour necrosis factor receptor. Gastroenterology 1995; 108: 1849-1854.
18. Sprenger H, Kaufmann A, Harn H, Lahme B, Gressner AM. Induction of neutrophil-attracting chemochines in transforming rat hepatic stellate cells. Gastroenterology 1997; 113: 277-285.
19. Nanji AA, Yang EK, Fogt F, Sadrzadeh SMH, Dannenberg AJ. Medium chain triglycerides and vitamin E reduce the severity of established experimental alcoholic liver disease. J Pharma Exper Ther 1996; 277: 1694-1699.
20. Parola M, Rubio M, Varela G, et al. Effects of S-adenosyl-methionine on lipid peroxidation and liver fibrogenesis in carbon tetrachloride-induced cirrhosis. J Hepatol 1996; 25: 2000-2005.
21. Friedman SL. The cellular basis of hepatic fibrosis: mechanisms and treatment strategies. N Engl J Med 1993; 328: 1828-1835.
22. Groszmann RJ, Atterbury CE. The pathophysiology of portal hypertension: a basis for classification. Sem Liver Dis 1982; 2: 177-186.
23. Rioux KP, Beck PL, Hoppin AG, et al. Differential leptin responses to acute and chronic biliary obstruction in rats. J Hepatol 2000; 33: 19-25.
24. Leonarduzzi G, Scavazza A, Biasi F, et al. The lipid peoxidation end-product 4-hydroxy-2,3-nonnenal up-regulates transforming growth factor beta1 expression in macrophage lineage: a link between oxidative injury and fibrosclerosis. FASEB J 1997; 11: 851-857.
25. Tang M, Potter JJ, Esteban M. Leptin enhances the effect of transforming growth factor β in increasing type I collagen formation. Biochem Biophy Res Comm 2002; 297: 906-911.
26. Gerber MA, Thung SN. Histology of the liver. Am J Surg Pathol 1987; 11: 709-722.
27. Fried MW. Therapy of chronic viral hepatitis. Med Clin North Am 1996; 80: 957-973.
28. Diehl AM. Cytokine regulation of liver injury and repair. Immunol Rev 2000; 174: 160-171.
29. Bruccoleri A, Gallucci R, Germolec DR, et al. Induction early-immediate genes by tumor necrosis factor contribute to liver repair following chemical-induced hepatoxicity. Hepatology 1997; 25: 133-141.
30. Cressman DE, Greenbaum LE, DeAngelis RA, et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996; 274: 1379-1383.
31. Gallucci RM, Simeneova PP, Toriumi W, Luster MI. TNF alpha regulates transforming growth factor-alpha expression in regenerating murine liver and isolated hepatocytes. J Immunol 2000; 164: 872-878.
32. Malagurnera M, Di Fazio I, Laurino A, Ferlito L, Romano M, Trovato BA. Serum interleukin 6 concentrations in chronic hepatitis C patients before and after interferon-alpha treatment. Int J Clin Pharmacol Ther 1997; 35: 385-258.